View More Recent Stories

Nov 15, 2021 07:00AM LAVA Therapeutics Provides Business Update and Reports Third Quarter Financial Results
Nov 11, 2021 10:08AM LAVA Therapeutics and The Antibody Society Present Emerging Cancer Therapies Virtual Symposium
Nov 9, 2021 06:30AM LAVA Therapeutics Expands Management Team with Three Key Appointments
Nov 4, 2021 07:00AM LAVA Therapeutics to Participate in the 12th Annual Jefferies London Healthcare Conference
Nov 2, 2021 07:00AM LAVA Therapeutics Announces Participation at Upcoming Scientific Conferences
Oct 15, 2021 07:03AM LAVA Therapeutics (LVTX) Granted FDA Orphan Drug Designation for LAVA-051 for the Treatment of Chronic Lymphocytic Leukemia
Oct 15, 2021 07:00AM LAVA Therapeutics Receives FDA Orphan Drug Designation for LAVA-051 for the Treatment of Chronic Lymphocytic Leukemia
View More Recent Stories